Literature DB >> 23219521

Serotonin receptor of type 6 (5-HT6) in human prefrontal cortex and hippocampus post-mortem: an immunohistochemical and immunofluorescence study.

Donatella Marazziti1, Stefano Baroni, Andrea Pirone, Gino Giannaccini, Laura Betti, Giovanna Testa, Lara Schmid, Lionella Palego, Franco Borsini, Fabio Bordi, Ilaria Piano, Claudia Gargini, Maura Castagna, Mario Catena-Dell'osso, Antonio Lucacchini.   

Abstract

Given the paucity of data on the distribution of serotonin (5-HT) receptors of type 6 (5-HT(6)) in the human brain, the aim of this study was to investigate their distribution in postmortem human prefrontal cortex, striatum and hippocampus by either immunohistochemical or immunofluorescence techniques. The brain samples were obtained from 6 subjects who had died for causes not involving primarily or secondarily the CNS. The 5-HT(6) receptor distribution was explored by the [(125)I]SB-258585 binding to brain membranes followed by immunohistochemical and immunofluorescence evaluations. A specific [(125)I]SB-258585 binding was detected in all the regions under investigation, whilst the content in the hippocampus and cortex being about 10-30 times lower than in the striatum. Immunohistochemistry and double-label immunofluorescence microscopy experiments, carried out in the prefrontal cortex and hippocampus only, since data in the striatum were already published, showed the presence of 5-HT(6) receptors in both pyramidal and glial cells of prefrontal cortex, while positive cells were mainly pyramidal neurons in the hippocampus. The heterogeneous distribution of 5-HT(6) receptors provides a preliminary explanation of how they might regulate different functions in different brain areas, such as, perhaps, brain trophism in the cortex and neuronal firing in the hippocampus. This study, taking into account all the limitations due to the postmortem model used, represents the starting point to explore the 5-HT(6) receptor functionality and its sub-cellular distribution.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219521     DOI: 10.1016/j.neuint.2012.11.013

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  10 in total

Review 1.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

2.  5-HT6 Receptor Recruitment of mTOR Modulates Seizure Activity in Epilepsy.

Authors:  Liang Wang; Yaodong Lv; Wanni Deng; Xi Peng; Zheng Xiao; Zhiqin Xi; Guojun Chen; Xuefeng Wang
Journal:  Mol Neurobiol       Date:  2014-07-18       Impact factor: 5.590

3.  Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes.

Authors:  Tania Vitalis; Mark S Ansorge; Alexandre G Dayer
Journal:  Front Cell Neurosci       Date:  2013-06-19       Impact factor: 5.505

4.  Effect of acute and chronic electroconvulsive shock on 5-hydroxytrypamine 6 receptor immunoreactivity in rat hippocampus.

Authors:  Hyun Jung Kim; Seungwoo Kang; Hyun Ju Kim; Sun-Hye Choi; Seungkeun Shin; Hyung Ha Lee; Hyewhon Rhim; Kyung Ho Shin
Journal:  Exp Neurobiol       Date:  2014-09-18       Impact factor: 3.261

Review 5.  Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.

Authors:  Alan L Pehrson; Connie Sanchez
Journal:  Drug Des Devel Ther       Date:  2015-01-19       Impact factor: 4.162

6.  A tricyclic antidepressant, amoxapine, reduces amyloid-β generation through multiple serotonin receptor 6-mediated targets.

Authors:  Xiaohang Li; Qinying Wang; Tingting Hu; Ying Wang; Jian Zhao; Jing Lu; Gang Pei
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

7.  Constitutive Activity of Serotonin Receptor 6 Regulates Human Cerebral Organoids Formation and Depression-like Behaviors.

Authors:  Qinying Wang; Xiaoxu Dong; Tingting Hu; Chao Qu; Jing Lu; Yue Zhou; Jinsong Li; Gang Pei
Journal:  Stem Cell Reports       Date:  2020-12-23       Impact factor: 7.765

8.  Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity-Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer's Disease.

Authors:  Krzysztof Więckowski; Natalia Szałaj; Beata Gryzło; Tomasz Wichur; Izabella Góral; Emilia Sługocka; Joanna Sniecikowska; Gniewomir Latacz; Agata Siwek; Justyna Godyń; Adam Bucki; Marcin Kołaczkowski; Anna Więckowska
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

Review 9.  A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)'s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression.

Authors:  Yan Li; Alan L Pehrson; Jessica A Waller; Elena Dale; Connie Sanchez; Maria Gulinello
Journal:  Front Neurosci       Date:  2015-08-10       Impact factor: 4.677

10.  Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors.

Authors:  Véronique Sgambato-Faure; Thierry Billard; Elise Météreau; Sandra Duperrier; Sylvain Fieux; Nicolas Costes; Léon Tremblay; Luc Zimmer
Journal:  Front Pharmacol       Date:  2017-07-18       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.